B. Parshall

B. Lynne Parshall currently works at Pinnacle Consulting LLC, as Chief Executive Officer from 2018, Celdara Medical LLC, as Director from 2023, Cytokinetics, Inc., as Independent Director from 2014, Foghorn Therapeutics, Inc., as Independent Director from 2022, Ring Therapeutics, Inc., as Director from 2022, Repertoire Immune Medicines, Inc., as Director from 2021, Alltrna, as Director from 2023, American Bar Association, as Member, The State Bar of California, as Member, Licensing Executives Society, as Member, and San Diego County Bar Association, as Member.
Ms. Parshall also formerly worked at Akcea Therapeutics, Inc., as Chairman from 2019 to 2020, Corautus Genetics, Inc., as Director, CardioDynamics International Corp., as Director from 2005 to 2009, Regulus Therapeutics, Inc., as Director from 2009 to 2015, Ionis Pharmaceuticals, Inc., as Director from 2018 to 2026, and Cooley LLP, as Partner from 1986 to 1991.
Ms. Parshall received her graduate degree from Stanford Law School and undergraduate degree from Harvard College.